Bonraybio Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also offers consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X… Read more
Bonraybio Co., Ltd. (6955) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.039x
Based on the latest financial reports, Bonraybio Co., Ltd. (6955) has a cash flow conversion efficiency ratio of 0.039x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$23.75 Million) by net assets (NT$611.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bonraybio Co., Ltd. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Bonraybio Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bonraybio Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bonraybio Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SKY Metals Ltd
AU:SKY
|
-0.041x |
|
Dicot AB
ST:DICOT
|
-0.278x |
|
SPARQ Corp.
OTCQB:SPRQF
|
-0.106x |
|
The BORN Korea
KO:475560
|
N/A |
|
Sriracha Construction Public Company Limited
BK:SRICHA
|
0.699x |
|
Surrozen Inc
NASDAQ:SRZN
|
0.384x |
|
Me2on Co. Ltd
KQ:201490
|
0.017x |
|
KPX Chemical
KO:025000
|
0.013x |
Annual Cash Flow Conversion Efficiency for Bonraybio Co., Ltd. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Bonraybio Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$571.35 Million | NT$80.14 Million | 0.140x | +45.21% |
| 2023-12-31 | NT$278.46 Million | NT$26.89 Million | 0.097x | +103.81% |
| 2022-12-31 | NT$252.80 Million | NT$11.98 Million | 0.047x | +144.76% |
| 2021-12-31 | NT$236.99 Million | NT$-25.09 Million | -0.106x | -- |